These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1809456)

  • 1. Use of troleandomycin as a steroid-sparing agent in both asthma and chronic obstructive pulmonary disease.
    Shivaram U; Cash M
    J Assoc Acad Minor Phys; 1991; 2(3):131-3. PubMed ID: 1809456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An improved protocol for the use of troleandomycin (TAO) in the treatment of steroid-requiring asthma.
    Wald JA; Friedman BF; Farr RS
    J Allergy Clin Immunol; 1986 Jul; 78(1 Pt 1):36-43. PubMed ID: 3487564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of low-dose troleandomycin on theophylline clearance: implications for therapeutic drug monitoring.
    Kamada AK; Hill MR; Brenner AM; Szefler SJ
    Pharmacotherapy; 1992; 12(2):98-102. PubMed ID: 1570234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylprednisolone and troleandomycin in treatment of steroid-dependent asthmatic children.
    Eitches RW; Rachelefsky GS; Katz RM; Mendoza GR; Siegel SC
    Am J Dis Child; 1985 Mar; 139(3):264-8. PubMed ID: 3872062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of low-dose troleandomycin on glucocorticoid pharmacokinetics and airway hyperresponsiveness in severely asthmatic children.
    Ball BD; Hill MR; Brenner M; Sanks R; Szefler SJ
    Ann Allergy; 1990 Jul; 65(1):37-45. PubMed ID: 2195921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Response of airflow to the administration of bronchodilator agents in patients with chronic obstructive lung disease or asthma].
    Barbas CS; Barbas Filho JV; do Amaral e Silva E; Stávale ML; Amato Mde P
    Rev Hosp Clin Fac Med Sao Paulo; 1991; 46(4):163-5. PubMed ID: 1843712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over.
    Tinkelman DG; Price DB; Nordyke RJ; Halbert RJ
    J Asthma; 2006; 43(1):75-80. PubMed ID: 16448970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incidence of corticosteroid side effects in chronic steroid-dependent asthmatics on TAO (troleandomycin) and methylprednisolone.
    Harris R; German D
    Ann Allergy; 1989 Aug; 63(2):110-1. PubMed ID: 2788376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of oxidative stress in asthma and COPD: potential inhibitory effect of theophylline.
    Tsukagoshi H; Shimizu Y; Iwamae S; Hisada T; Ishizuka T; Iizuka K; Dobashi K; Mori M
    Respir Med; 2000 Jun; 94(6):584-8. PubMed ID: 10921764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The place of long-acting beta 2 adrenergic agonists in the treatment of asthma and chronic obstructive lung disease (COPD)].
    van Schayck CP; Postma DS; Lammers JW
    Ned Tijdschr Geneeskd; 1999 Jan; 143(3):137-40. PubMed ID: 10086126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypomagnesemia in chronic obstructive lung disease: effect of therapy.
    Rolla G; Bucca C; Bugiani M; Oliva A; Branciforte L
    Magnes Trace Elem; 1990; 9(3):132-6. PubMed ID: 1979000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
    Donohue JF; Hanania NA; Ciubotaru RL; Noe L; Pasta DJ; Schaefer K; Claus R; Andrews WT; Roach J
    Clin Ther; 2008; 30 Spec No():989-1002. PubMed ID: 18640474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety and tolerability of adenosine in patients with obstructive airways disease.
    van Gaal WJ; Couthino B; Chan M; Allman KC
    Int J Cardiol; 2008 Aug; 128(3):436-8. PubMed ID: 17655953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral doxophylline in patients with chronic obstructive pulmonary disease.
    Villani F; De Maria P; Ronchi E; Galimberti M
    Int J Clin Pharmacol Ther; 1997 Mar; 35(3):107-11. PubMed ID: 9088999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value and the tolerance of troleandomycin in the long-term treatment of asthma and chronic bronchitis.
    Cabanieu G
    Quad Antibiot; 1975 Jun; ():110-21. PubMed ID: 1088732
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of theophylline on lung function and sleep in patients with severe chronic obstructive pulmonary disease].
    Li Y; Liu Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Oct; 20(5):294-8. PubMed ID: 10374456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment with inhalation corticosteroids: useful or useless in chronic obstructive pulmonary disease (COPD)?].
    van Schayck CP
    Ned Tijdschr Geneeskd; 1999 Apr; 143(15):778-80. PubMed ID: 10347639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Home monitoring of theophylline levels: a novel therapeutic approach.
    Chandler MH; Clifton GD; Louis BA; Coons SJ; Foster TS; Phillips BA
    Pharmacotherapy; 1990; 10(4):294-300. PubMed ID: 2388876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Theophylline treatment of irreversible, chronic obstructive pulmonary disease].
    Iversen ET; Eiken PA; Nielsen LM; Laursen LC; Maltbaek N; Tønnesen FV; Rasmussen FV
    Ugeskr Laeger; 1994 Sep; 156(39):5696-9. PubMed ID: 7985256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of theophylline on ventilatory regulation in patients with chronic obstructive pulmonary disease].
    Ikeda A; Senju S; Toyoshima H; Miyahara S; Aritomi T; Watanabe K; Ishibashi M; Yoshida M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Nov; 31(11):1441-8. PubMed ID: 8277616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.